Analystreport

Trillium Therapeutics Inc (NASDAQ: TRIL) had its price target raised by analysts at JMP Securities from $10.00 to $14.00. They now have an "outperform" rating on the stock.

Trillium Therapeutics Inc. - Common Shares  (TRIL) 
Last trillium therapeutics inc. - common shares earnings: 5/13 07:00 am Check Earnings Report